Literature DB >> 11897970

Use of alternative specimens: drugs of abuse in saliva and doping agents in hair.

Pascal Kintz1, Nele Samyn.   

Abstract

It is generally accepted that chemical testing of biologic fluids is the most objective means of diagnosis of drug use. The presence of a drug analyte in a biologic specimen can be used to document exposure. The standard for drug testing in toxicology is an immunoassay screen conducted on a urine sample, followed by confirmation by gas chromatography with mass spectrometric detection. In recent years, remarkable advances in sensitive analytic techniques have enabled the analysis of drugs in unconventional biologic specimens such as saliva or hair. The aim of this review is to document the current status of drugs of abuse testing in saliva and some doping agents in hair. The influence on drug concentration of the procedure of saliva sampling is described. Screening procedures along with specific methods are reviewed for the determination of amphetamines, cannabis, cocaine, and opiates in saliva. Before an extensive review on the detection of anabolics, corticosteroids, and beta-adrenergic stimulants in hair, the place of this specimen in doping control is discussed, with a focus on the potential problems of this new technology.

Entities:  

Mesh:

Year:  2002        PMID: 11897970     DOI: 10.1097/00007691-200204000-00006

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  10 in total

1.  Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.

Authors:  Garry Milman; Allan J Barnes; David M Schwope; Eugene W Schwilke; Robert S Goodwin; Deana L Kelly; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2011-06-03       Impact factor: 4.142

2.  Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

Authors:  Garry Milman; David M Schwope; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-01-20       Impact factor: 3.786

3.  Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping.

Authors:  Bettina Link; Manuel Haschke; Nathalie Grignaschi; Michael Bodmer; Yvonne Zysset Aschmann; Markus Wenk; Stephan Krähenbühl
Journal:  Br J Clin Pharmacol       Date:  2008-04-11       Impact factor: 4.335

4.  MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.

Authors:  Allan J Barnes; Karl B Scheidweiler; Erin A Kolbrich-Spargo; David A Gorelick; Robert S Goodwin; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

Review 5.  The potential role of oral fluid in antidoping testing.

Authors:  Sebastien Anizan; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-10-23       Impact factor: 8.327

6.  Drug testing in oral fluid.

Authors:  Olaf H Drummer
Journal:  Clin Biochem Rev       Date:  2006-08

7.  Quantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry.

Authors:  Allan J Barnes; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2014-04       Impact factor: 3.681

Review 8.  Human body burdens of chemicals used in plastic manufacture.

Authors:  Holger M Koch; Antonia M Calafat
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-07-27       Impact factor: 6.237

9.  Detecting cannabis use on the human skin surface via an electronic nose system.

Authors:  Andreas Voss; Katharina Witt; Tobias Kaschowitz; Wolf Poitz; Andreas Ebert; Patrik Roser; Karl-Jürgen Bär
Journal:  Sensors (Basel)       Date:  2014-07-23       Impact factor: 3.576

10.  Comparison of 3 Derivatization Methods for the Analysis of Amphetamine-Related Drugs in Oral Fluid by Gas Chromatography-Mass Spectrometry.

Authors:  Khaled M Mohamed; Abdulsallam Bakdash
Journal:  Anal Chem Insights       Date:  2017-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.